Thalia Marie Blicher

Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea

Julio Rosenstock, Andreas L. Birkenfeld, Thalia Marie Blicher et al. · JAMA · 2019 · 398 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund et al. · The Lancet Diabetes & Endocrinology · 2019 · 342 citations · Full text

Medicine, Nephrology, Pharmacology +13

Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes

Charlotte Granhall, Morten Donsmark, Thalia Marie Blicher et al. · Clinical Pharmacokinetics · 2018 · 179 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Less use of standard guideline-based treatment of myocardial infarction in patients with chronic kidney disease: a Danish nation-wide cohort study

Thalia Marie Blicher, Kristine Hommel, Jonas Bjerring Olesen et al. · European Heart Journal · 2013 · 33 citations · Full text

Medicine, Cardiology, Internal Medicine +13

Use of nonsteroidal anti‐inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study

Søren Lund Kristensen, Emil Loldrup Fosbøl, Anne‐Lise Kamper et al. · Pharmacoepidemiology and Drug Safety · 2012 · 19 citations

Medicine, Nephrology, Pharmacotherapy +13